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Contamination of the environment by metals is recognized as a threat to health. One of their targets is the brain, and the adverse
functional eﬀects they induce are reﬂected by neurobehavioral assessments. Lead, manganese, and methylmercury are the metal
contaminants linked most comprehensively to such disorders. Because many of these adverse eﬀe c t sc a na p p e a rl a t e ri nl i f e ,
clues to the role of metals as risk factors for neurodegenerative disorders should be sought in the exposure histories of aging
populations. A review of the available literature oﬀers evidence that all three metals can produce, in advanced age, manifestations
of neurobehavioraldysfunction associatedwith neurodegenerative disease. Among the critical unresolved questions is timing; that
is, during which periods of the lifespan, including early development, do environmental exposures lay the foundations for their
ultimate eﬀects?
1.Introduction
In soliciting contributions for this special issue of the Inter-
national Journal of Alzheimer’s Disease, the editors featured
the metals copper, zinc, iron, and aluminum. Except perhaps
for aluminum, none of the four are considered to be major
environmental hazards for neurodegenerative disorders. The
three metals addressed in this paper provide a contrasting
view. Lead, organic mercury, and manganese are identiﬁed
as environmental risk factors for such disorders because of
the scale of their distribution. It is worth reviewing how
they achieved this status because such an appraisal may oﬀer
a useful model for the ways in which we evaluate the heath
risks of other metals as well as those discussed here.
Environmental neurotoxicology adopted a view of the
coupling of metal exposure and disease determined by its
early connections to risk assessment. It approached its eval-
uations from angles dictated by legislation and regulation,
especially after passage, by the US Congress, of the Toxic
Substances Control Act (TSCA), signed into law in 1976.
As practiced by the US Environmental Protection Agen-
cy, and, in fact, by its counterparts in other nations, its
primary task is to determine the health risks of exposure to
environmental agents, quantify them, and then prescribe
exposure standards that oﬀer an adequate margin of safety.
Although economic impacts are to be considered, typically,
because exposures to environmental chemicals oﬀer no
healthbeneﬁts, thehealthrisks assume priority andexposure
standards are sought that oﬀer a robust margin of safety. The
standards are not formulated speciﬁcally to protect against
clinical disorders such as Alzheimer’s disease. Instead, the
margin of safety is designed to provide a buﬀer against even
minimal adverse eﬀects. The exposure criterion is designated
as the Reference Dose (RfD) and is deﬁned as “An estimate,
with uncertainty spanning perhaps an order of magnitude,
of a daily oral exposure to the human population (including
sensitive subgroups) that is likely to be without an apprecia-
ble risk of deleterious eﬀects during a lifetime.” This deﬁni-
tion is pertinent to disease etiology because it underscores
the developing consensus that neurodegenerative disorders
may originate in events and circumstances that antedate,
even by decades, their overt clinical manifestations. Further,
the ﬁrst indications of such a progression may take the
form of subtle, insidious, minimal toxic manifestations that
foreshadow the emergence of clinically apparent disorders
[1].
Long before the concept of environmental protection
arose, along with its regulatory machinery, all three metals2 International Journal of Alzheimer’s Disease
Table 1: Age-speciﬁc incidence rates for Alzheimer’s disease. Mean
estimates are the averages of the smoothed age-speciﬁc incidence
curves from these studies [2].
Age, years Estimate
60 0.08
65 0.17
70 0.35
75 0.71
80 1.44
85 2.92
90 5.95
95 12.10
had been identiﬁed as neurotoxicants. Lead and mercury
had been acknowledged as poisons even in ancient texts.
Manganese came to be viewed as a neurological poison
in the 19th century. The new principles of environmental
protectionchangedtheequationtoafocusonearly detection
of potential adverse eﬀects.
The connection between the principles and practices
of environmental protection and the role of metals in
neurodegenerative disorders may seem superﬁcially remote.
It is, in fact, one model for how we might formulate research
on that question and how to convert that research into
practice. That model emphasizes the early stages of the
progression to a clinical entity.
The perspective adopted by this paper adheres to that
approach. One way in which it might be depictedgraphically
appears in Figure 1. It was formulated originally [3]t os h o w
how even a small shift in the IQ distribution of a population
exposed to elevated levelsof lead can create disproportionate
consequences at the extremes of the distribution. As shown
there, a 5% lowering of the mean (5 IQ points on standard-
ized tests) leads to a 57% increase in the proportion of the
population classiﬁed as “retarded,” a deﬁnition based on the
usual criterion of an IQ of 70. With a mean of 100, the usual
standardized mean, and a standard deviation (SD) of 15, as
on the Stanford-Binet, an IQ of 70 lies two SDs below the
mean.
Figure 1 is only a model for how to depict a speciﬁc
measure. A similar chart could be made for a component of
cognitive function such as memory. On a population basis,
most aspects of cognitive function decline with age. Accord-
ing to the analysis of Hedden and Gabrieli [4], these include
inductive reasoning, spatial orientation, perceptual speed,
and verbal memory. Vocabulary remains intact or improves.
Drag and Bieliauskas [5] also noted that vocabulary remains
resistant to aging and may even improve, but that both long-
term and short-term memory and processing speed decline.
Allshow distributionsofscoresthatﬁt themodel in Figure 1.
Assume, provisionally, that for a selected age group, we
plot a distribution of an ability, such as memory, as in
Figure 1. With progressively older age groups, the mean of
the distribution will shift to lower scores, which means that
an increasingly greater proportion of that population will
fall within what we might deﬁne as a zone of impairment.
W em i g h td e ﬁ n es u c haz o n ea st h a tp r o p o r t i o nt w oS D s
or more below the mean of a criterion group such as adults
25–45 years of age. With a typical normal or bell-shaped
distribution, the older the age group is, the greater will
be the impact of a speciﬁc shift in the mean, such as one
caused by an environmental exposure because a greater total
percentage of the age group will fall into the impairment
zone. Put another way, the exposure is not a direct cause
of the disease; rather, it shifts the population’s cognitive
performance toward scores that are characteristic of an older
population.
Neurodegenerative diseases follow a pattern, as exem-
pliﬁed by Alzheimer’s disease (AD), in which prevalence
increases with age. Brookmeyer et al. [2]c a l c u l a t e da g e -
speciﬁc incidence rates for AD from a body of data provided
by four studies. Their mean estimates are the averages of the
smoothed age-speciﬁc incidence curves from these studies.
Their predicted percentages of cases per age group appear
in Table 1. Hebert et al. [6], based on their studies of
three Chicago populations, show striking changes in the
proportions of individuals within three age groups (65–
74, 75–84, and >85) in the scores attained on the Mini-
Mental State Examination (MMSE), with a sharp rise in the
severe category in patients over 85 years of age. Thus, both
diminished cognitive function and AD follow an equivalent
a g ep a t t e r n .W e r eM M S Es c o r ed i s t r i b u t i o n st ob es h i f t e d
downward in an exposed population by, say, 5%, we could
legitimately interpret the exposure as a risk factor for AD.
In the following discussions of lead, manganese, and
mercuryIwillreviewdataindicatingthat,atenvironmentally
relevant levels, such exposures augment the expected decline
in neurobehavioral function associated with aging. I will use
these data to argue that such exposures then constitute risk
factors for neurodegenerative disease states. That is, they
wouldnot belabeledasthe primary sources ofthese diseases.
Rather, (1) they elevate the likelihood that latent factors,
such as genetic predispositions, will ﬁnd overt expression
or (2) they cause the clinical form of the disease to appear
earlier in the lifespan. For example, the onset of clinically
diagnosed AD is often preceded by a transitional phase
termed mild cognitive impairment (MCI). It describes a
conditioninwhich neuropsychologicalfunction,particularly
memory, is compromised, but not enough to meet the
criteria for a clinical diagnosis of AD, recognizing that the
ultimate criterion for such a diagnosis is neuropathology. If
an environmental exposure itself is able to magnify MCI, it
wouldbeconsideredariskfactorforclinicallymanifestedAD
as well as a condition that diminishes the individual’s quality
of life.
2.Lead
Although identiﬁed as a neurotoxicant as long ago as the
second century BCE, its eﬀects on neurobehavioral devel-
opment have generated the greatest volume of research
during the past ﬁve decades. Eﬀects on adults occupy only
a small proportion of the contemporary literature, and
eﬀects during advanced age an even smaller proportion.International Journal of Alzheimer’s Disease 3
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Figure 1: Showingthe consequences ofa shift in the population IQ
of 5 points (5%) in a population of 100 million. In most US school
districts, an IQ of 70 or lower (2 SDs below the mean) mandates
remedial action. (Based on Weiss [3]).
That imbalance is slowly undergoing a shift, one propelled
by increasing recognition of the health risks posed to
a ballooning population of the elderly. Among the risks
arousing the greatest concernsare those bearing on cognitive
function. Other clinical entities such as osteoporosis and
hypertension can be treated with drugs, which is a useful
property given that lead is a risk factor for hypertension,
coupled with the connections between hypertension and
multi-infarct dementia as well as with cognitive decline.
Cognitive dysfunction itself, at this stage of knowledge, lies
mostly outside the realm of pharmacotherapy.
The US Centers for Disease Control and Prevention
(CDC) has set a value of 10 micrograms of lead per deciliter
Table 2: Signs of manganese poisoning.
(i) Impaired coordination
(ii) Abnormalgait
(iii) Abnormallaughter
(iv) Expressionless face
(v) Weakness
(vi) Bradykinesia
(vii) Somnolence
(viii) Dysarthria
(ix) Diﬃculty walking
(x) Clumsiness
(xi) Lack of balance
(xii) Muscle pains
(xiii) Diminished leg power
of blood (μg/dL) as the level at which it recommends that
public health actions be initiated for young children because
of the recognized vulnerability of the developing brain. This
value is the latest in a progression of exposure criteria that
have evolved in parallel with accumulating information
about the scope of lead neurotoxicity and the low levels
at which neurotoxicity is observed. Gilbert and Weiss [7],
however, have argued that this value is too high and that
2μg/dL is a more reasonable ﬁgure given that no discernible
threshold for lead toxicity has been established.
What can be gleaned from the current lead literature is
that older adults appear to be as vulnerable as children to
lead neurotoxicity. Muldoon et al. [8] measured neuropsy-
chological function in a cohort of elderly women and found
that levels as low as 8μg/dL were signiﬁcantly associated
with poorer cognitive function. As they noted, “even a slight
decrement in cognition would have a large public health
impact due to the large number of elderly at risk.”
Subsequent studies have relied more on measures of
skeletal lead than of blood lead because the half-life of
lead in the latter is about 35 days while the half-life in
the skeleton, depending on the assay location, can be as
much as two decades. Skeletal measures, based on X-ray
ﬂuorescence (XRF)methods, have the virtue, in olderadults,
of providing a historical and cumulative index of exposure
[9], a considerable advantage because lead is so embedded
in the environment that epidemiological studies cannot
readily distinguish the eﬀects of recent from past exposures.
In one study [10], which surveyed nearly 1,000 adults in
Baltimore, Maryland, performance scores on a variety of
neuropsychological tests were found to be associated with
tibia lead concentrations (language, processing speed, eye-
hand coordination, executive functioning, verbal memory
andlearning,andvisualmemory).Themeanbloodleadlevel
a tt h et i m eo ft e s t i n gw a s3 . 2μg/dL.
In another study of an elderly population in Boston
[11], the investigators measured bone lead in about 1,100
men at various times between 1991 and 1999. In this
population, performance over this period on a battery of
neuropsychological tests worsened as bone lead increased.
The most robust eﬀects were reﬂected by performance and4 International Journal of Alzheimer’s Disease
MRI of Mn in globus pallidus
Unexposed Exposed
Figure 2:Magneticresonanceimagesoftwomonkeys,oneexposed
to inhaled manganese and one contol. They show that manganese
achieves high concentrations in the global pallidus. Based on
Newland and Weiss [12].
reaction time scores on visuospatial/visuomotor tests. Here,
mean blood lead values lay in the range of 5μg/dL. The
authors, in describing the rationale for their study and its
implications for AD, commented as follows: “Mild cognitive
impairment is more prevalent than AD and is receiving
increasing attention,not onlyasapossibleintermediate stage
on the path to AD, but as an important deﬁcit in its own
right.”The argument ofGilbert and Weiss[7] that acceptable
lead levels be reduced applies to adults as well as children.
Because women had been underrepresented in lead
studies, Weuve et al. [13] chose a population from the
Nurses Health Study, which began in 1976. Over 90% of
the participants have continued to participate, completing
mail questionnaires every two years. Nearly 600 women took
part in the current study and ranged in age from 47 to 74.
They underwent cognitive testing and bone and blood lead
assessment. Remarkably, mean blood lead values lay in the
2-3μg/dL range. As noted by the authors, current values do
not reﬂect the much higher exposures that prevailed in the
past.Notuntil1971didtheUSCongresspasstheLead-Based
Paint Poisoning Prevention Act, and not until 1986 was the
phase out of lead from gasoline completed. As a result of this
action, mean US blood-lead levels declined by 78 percent
from 1978 to 1991. As noted earlier, however, the legacy of
earlier environmental lead exposures remains implanted in
the individual, eithervisibly in the skeleton, or epigenetically
[14] or covertly, as silent neural damage that is not revealed
untilthecompensatory capacityofthebrain hasbeen eroded
by aging [15].
Generally, cognitive assessment occurred ﬁve years fol-
lowing the exposure assessments. The tests were conducted
by trained nurses and administered by telephone interviews.
The assessment battery consisted primarily of memory tests.
As in the aging study in men, the concentration of lead
in tibia bone was associated with worse overall cognitive
performance. The authors translated this decrement into an
age eﬀect as follows: “Speciﬁcally, the average decrement in
cognitivetest scoreswe observedfor each SDincrease in tibia
lead corresponded to the decrement in scores we observed
for each 3-year increase in age among women in our study.”
Put another way, lead exposure induced premature aging, in
essence shifting the score distribution to lower values.
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Figure 3:Depicting thephenomenonofdelayed onsetofneurotox-
icity with methylmercury in nonnuman primates (a) and (b) in the
Minamata population [18, 19].
Most neuropsychological tests are based on the needs
of clinical practice and were designed to assist in the
diagnosis in individual patients. Performance testing adopts
ad i ﬀerent point of view, one stemming from the needs
of laboratory investigators, whose aim is to determine
the eﬀects of some experimental procedures on a speciﬁc
behavior in a population sample. Proceeding from this
standpoint, van Wijngaarden et al. [16] assessed a group
of healthy subjects 55–67 years of age on a battery of
behavioral tests derived from procedures originally devel-
oped in the animal laboratory. These procedures, part of
the Cambridge Neuropsychological Test Automated Battery
(CANTAB), were selected because they had been shown
to reﬂect the kinds of impairment characteristic of AD.
They included delayed matching-to-sample (DMS), paired
associate learning (PAL), and spatial recognition memory
(SRM). In addition, the subjects completed the Montreal
Cognitive Assessment (MoCA) as an index of MCI.
As in other recent studies, the authors relied on XRF of
bone to capture an index of cumulative lead exposure. And,
following conventionalpractice, they corrected for a number
of covariates that might serve as confounders such as age,
smoking, alcoholuse, body mass index (BMI),and others. In
this pilot sample of 47 subjects, the clearest associations with
exposure were seen with the DMS procedure, which calls
upon the subject to select, after a variable delay, one of four
complex visual patterns that matches a single test pattern
shown before the delay. A similar task revealed deﬁcits
in nonhuman primates exposed chronically to manganese
[17]. The other two CANTAB tests (SRM and PAL) also
showed signiﬁcant associations with bone lead, but not as
conspicuously as the DMS procedure. The MoCA inventory
showed only a weak association.International Journal of Alzheimer’s Disease 5
Full Minamata syndrome
Partial Minamata syndrome
Latent MM Neurotoxicity
Figure 4: Schematic of scope of neurotoxic signs stemming from
exposure to methylmercury. The full syndrome, as in Table 3,
occurs with massive exposures. The primary current question,
a population question, arises from the possible occurrence of
subtle neuropsychological deﬁcits that would only be evident with
systematic testing; that is, latent eﬀects.
The message conveyed by these recent publications tells
us that historical and cumulative as well as current lead
exposure must be considered a risk factor for neurobehav-
ioral dysfunction, including a decline in cognitive perfor-
mance. Translating these ﬁndings into the model depicted
in Figure 1, it will be seen that lead exposure shifts the test
score distribution toward lower values. The result is that a
larger proportion of the population falls into the range of
markedly diminished cognitive function—a basic criterion
fordementia.Or,asnotedearlier, becausepopulationindices
of cognitive function also decline with age, it shifts the scores
toward more advanced ages; that is, premature aging.
One other aspect of these data warrants comment,
although we have no direct evidence of their impact in
human populations. Environmental health specialists now
view as a principle the notion that toxic exposures during
early development create the foundation for adult disease.
A substantial literature in neurotoxicology testiﬁes to the
validity of that principle for neurobehavioral function.
Recent research links developmental lead exposure to ele-
vated deposits of β-amyloid deposits in both aged rats [20]
and monkeys [21], leading the authors to propose a two-
stagemodelforthegenesisofdementia.Stageoneistriggered
by a condition such as lead exposure, which inscribes an
epigenetic footprint in the form of altered patterns of DNA
methylation. Stage two occurs late in life, possibly a result
of further stress, including diminished brain compensatory
capacity. Acting in concert, this combination of stressors is
postulated to evoke the pathogenic processes that underlie
dementia. Whether and how such a sequence eventually
results in impaired performance on behavioral tests late in
life is a question that warrants further exploration.
3.Manganese
Manganese (Mn) has been recognized as a neurotoxic metal
for over 150 years. Exposure to high levels of inhaled
manganese, as in miners worki n gi na ne n v i r o n m e n tl a d e n
with dust from manganese ore (MnO2), leads to a constel-
lation of psychological and motor symptoms depicted in
Table 2. The psychological changes are known as “locura
Table 3: Scope of methylmercury poisoning experienced in Japan
beginninginthe1950s.ThissyndromebecameknownasMinamata
Disease. Later, when the eﬀects of prenatal exposure became
evident, a new category, Fetal Minamata Disease, was established.
SENSORY
(i) Paresthesia (numbness and tingling)
(ii) Pain in limbs
(iii) Visual disturbances (ﬁeld constriction)
(iv) Hearing disturbances
(v) Asterognosis (discriminationby touch)
MOTOR
(i) Disturbances of gait
(ii) Weakness,leg unsteadiness, falling
(iii) Thick, slurred speed (dysarthria)
(iv) Tremor
OTHER
Headaches, rashes, “mental disturbance”
manganica” in the South American manganese mines where
manganism is endemic. Many of the motor and postural
signs are consistent with those of Parkinson’s disease (PD),
an overlap that has led to debates about whether manganese
neurotoxicityistrulya formofPD.Most observersagree that
the movement disorders induced by manganese exposure
and idiopathic Parkinsonism diﬀer in fundamental respects.
PDpatientstypicallywalkwithshuﬄinggait. Inmanganism,
patients may walk with an almost theatrical high-stepping
gait. Dopamine replacement can attenuate PD signs; it has
little eﬀect on manganism. In PD, degeneration is seen
primarily in the substantia nigra; in manganism, it is seen
primarily in the globus pallidus.
Because manganese is paramagnetic, it can be localized
in the brain by magnetic resonance imaging (MRI). Figure 2
shows twoimages, onefrom a monkeyexposed byinhalation
and one from a control subject [12]. The ﬁgure shows the
tendency of inhaled manganese to collect in the globus
pallidus. A similar pattern of distribution occurs in humans
as well [22].
The overtly observable manifestations of overt man-
ganese poisoning have obscured the more subtle, more
widespread consequences of low-level exposures, much as
the overt signs of Parkinson’s disease have tended to eclipse
its neuropsychological accompaniments such as cognitive
impairment and depression. In parallel, at lower levels of
exposure than those associated with mining, such as those
experienced by welders exposed to manganese fumes from
welding rods, or to fumes by workers in ferromanganese-
processing plants, or in areas where air or water levels are
elevated, the manifestations are far less dramatic. They do
not rise to the levelofclinical detection. Instead, they require
the application of neuropsychological tests.
Two aspects of manganese neurotoxicity render it a
more diﬃcult question to resolve than is the case with
lead and mercury. First, it is an essential element. It is
required to maintain health as well as to support growth and
development. It is present in our tissues and is necessary for6 International Journal of Alzheimer’s Disease
certain biochemical reactions. Environmental levels cannot
be reduced to zero. Second, perhaps because it is an essential
element, no unambiguous biological marker, of the kind we
have for lead and mercury, is available. Blood Mn seems to
be the best commonly available index of exposure.
Fromthe standpoint ofgeneral populationrisk, themain
questions posed by manganese exposure lie more in the
realm of neuropsychological function than in the realm of
motor function. It must be recognized, however, that the
two realms are intertwined. Both spatially and functionally,
the brain is highly interactive. Simply because the globus
pallidus is part of the basal ganglia does not isolate it from
cognitive pathways. For example, McNab and Klingberg [23]
demonstrated,withfMRI,howworking memorydependson
pallidal and frontal cortical cooperation, so to speak.
Inhalation is the predominant mode of exposure leading
to neurotoxicity. For chronically exposed individuals, the
latency to clinical manganism is highly variable, dependent
on ambient concentrations, particle size, and individual
susceptibility. In some instances, it apparently surfaces long
after exposure has ceased. Because incipient poisoning may
beexpressed primarilybysubjective symptoms suchasmood
changes, a connection to manganese is easily overlooked.
This is the rationale for neuropsychological testing. As
in other neurotoxic syndromes, systematic testing is more
sensitive than the typical neurological examination. It is
why the cognitive eﬀects of manganese neurotoxicity were
virtually ignored until the last two decades. They were
submerged by the more blatant signs such as the motor
abnormalties and the striking emotional displays such as
hysterical laughing and weeping. More recently, however, we
have begun to realize that cognitive deﬁcits remain and may
even worsen, years after exposure has ceased [24]. Perhaps
even more worrisome, cognitive and associated measures of
neurobehavioralfunction havebeendocumented inchildren
[25]. Such losses, we now recognize, may persist for a
lifetime, perhaps lying dormant until advanced age.
The cognitive deﬁciencies embrace a variety of measures.
Theyincludediminished attention,reducedscoresontestsof
working memory, lowerscoreson intelligencetests,impaired
learning, and slowed response speed. The recent literature
expands these ﬁndings, as exempliﬁed by two recent papers.
Diminished neuropsychological function (such as attention
and memory) is detectable at about the same exposure levels as
the motor deﬁcits typically thought of as most characteristic of
manganism. Bowler et al. [24]e x a m i n e d4 7w e l d e r sa n d4 2
controls on a variety of tests: the Wechsler Adult Intelligence
Scale (WAIS-III), the Wechsler Memory Scale (WMS-III),
the Boston Naming Test, the Wide Range Achievement
Test (WRAT-3), Cancellation H, Trail Making Tests A and
B, Auditory Consonant Trigrams, Stroop (color naming)
test, Rey-Osterreith, Animal Naming, Controlled Oral Word
Association (COWAT), Test of Memory Malingering, Rey
15-item, Fingertapping, Grooved Pegboard, Dynamometer,
Visual Attention Test, and the Lanthony d-15 Color Vision
test. They saw diminished performance, among the welders,
in motor skills, visuomotor tracking speed and informa-
tion processing, working memory, verbal skills (COWAT),
delayed memory, and visuospatial skills.
Concentrations of manganese in the globus pallidus are
correlated with neuropsychological test performance.C h a n g
et al. [22] administered a battery of such tests to subjects
who had also been evaluated by MRI. To 43 asymptomatic
male welders and 29 age- and sex-matched healthy controls,
they administered the following tests: Digit symbol, auditory
verbal learning test (delayed recall), complex ﬁgure test
(copy and immediate recall), digit span, verbal ﬂuency test,
Stroop test,grooved pegboard, ﬁnger tapping, and frequency
dispersion and harmonic index of tremor. They also assessed
olfactory function and mood. Welders attained lower scores
than controlson severalcognitivetests,but,most interesting,
multiple regression analyses revealed pallidal index to be a
better predictor of performance in welders than blood Mn.
(Pallidal index was deﬁned as the ratio of the signal intensity
of the globus pallidus to that of thes u b c o r t i c a lf r o n t a lw h i t e
matter in axial T1-weighted MRI planes.).
Nonhuman primates are viewed as the most appropri-
ate animal model for studies of manganese neurotoxicity
because of their similarities to humans in brain anatomy and
neurobehavioral function. Two recent publications indicate
the depth and extent of understanding that can be achieved
by making use of these characteristics.
Schneider et al. [17] trained Cynomologous monkeys on
three memory tasks: spatial working memory (delayed posi-
tion choice), nonspatial working memory (delayed match-
to-sample), and reference memory (pattern discrimination).
Once trained, they were placed on a regimen of intravenous
manganese sulfate injections over a period of about 230
days. When tested at the end of this period, the treated
animals displayed mild deﬁcits in spatial memory, greater
deﬁcits in nonspatial memory, and no deﬁcits in reference
memory. By analyzing regional Mn concentrations, the
experimenters determined a signiﬁcant inverse relation-
ship between working memory task performance and Mn
levels.
In a direct quest for associations between manganese
exposure and Alzheimer’s disease, Guilarte [26] conducted
a gene array analysis of frontal cortex tissue from the same
animals. Of the 61 upregulated genes, the most highly
elevated was Amyloid-β Precursor-like Protein 1 (APLP1),
a member of the Amyloid Precursor Protein (APP) family.
Along with this ﬁnding, immunochemistry showed the
presence of Amyloid-β plaques, an unexpected ﬁnding given
that the subjects were only 6–8 years of age. In addition,
immunochemistry revealed the presence of α-synuclein
aggregates,whichhavebeenlinkedtoPDaswellasAD.These
ﬁndings, then, link the Mn-induced β-amyloid deposits to
impaired memory function in a species generally considered
tobe anespecially useful modelforextrapolation tohumans.
Because manganese exposure seems primarily to occur
via inhalation, I would be remiss in not observing current
data about the mechanics of ambient particulates. They
have received considerable attention as risk factors for
cardiovascular disease. We are now aware that the smallest
particles, termed ultraﬁne or nanoparticles, may directly
enter the central nervous system as they travel along the
olfactory nerve. In rats exposed to manganese oxideultraﬁne
particles for 12 days, Elder et al. [27] found these particlesInternational Journal of Alzheimer’s Disease 7
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Figure 5: Substantia nigra cell populations diminish with age, as
shown by McGeer et al. [31]. At about age 72, about 40% of the
cells have been lost. If the decline is accelerated by 0.1% per year,
such a loss would occur at about age 64.
translocating into the striatum, frontal cortex, and cerebel-
lum. This is an exposure pathway that needs considerably
more attention from the standpoint of neurodegenerative
disease [28, 29].
4.Methylmercury
An ecological disaster in Japan provided one of the earliest
signals about how chemical contamination of the envi-
ronment could engender major threats to human health,
particularly brain function. Perhaps even more than Rachel
Carson’s Silent Spring, which lamented the disappearance of
bird song [30], it framed its message in images of deformed
children and crippled adults. The chemical contaminant was
methylmercury and the site was in Japan, on the island of
Kyushu, in the small ﬁshing village of Minamata. There,
beginning in the 1950s, the inhabitants began to suﬀer
from a strange neurological disease traced to methylmercury
contamination of ﬁsh and shellﬁsh from Minamata bay. The
ﬁrst cases were sporadic, but, with time, more and more
cases became evident and ﬁnally led to an investigation that
indicted mercury dumped into the bayby a chemical factory.
The clinical signs of methylmercury poisoning are listed in
Table 3.
The story has been told many times, but none as
graphically as in the photographic essay by E. Smith and
A. Smith [32]. Since then, methylmercury has been the
subject of severalthousand scientiﬁc papers and still presents
numerous mysteries [33].
The overwhelming proportion of publications dealing
with methylmercury neurotoxicity is devoted to early brain
development [34, 35]. Although one of the earliest contri-
butions to methylmercury research reported that perinatal
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Figure 6: The chart demonstrates how the age-adjusted functions
of a disorder such as Parkinson’s disease are modiﬁed by an
acceleration of cell loss as depicted in Figure 5.A ta g e6 5y e a r s ,
the prevalence without acceleration is, based on available data,
about 700/100,000. If advanced by 5 years, the prevalence would be
1,200/100,000.
exposure in mice could induce adverse consequences that
might erupt eventually in advanced age [36], that portion of
the lifespan has still received relatively little attention.
The paucity of this literature fails to match the scope
of the problem. We are exposed to methylmercury almost
exclusivelythroughﬁsh consumption.Oneexceptionwasthe
mass poisoning inIraq in1971-1972,butitssource wasgrain
treated with a methylmercury fungicide [37, 38]. Exposures
therefore tend to continue through a lifetime in those whose
diet includes ﬁsh. Even as a consequence of developmental
exposure alone, we must address the possibility that expo-
sures early in life may produce undetected, latent, or “silent”
damage that emerges only when the functional capacities
of the nervous system are challenged by other conditions,
such as aging [39, 40] as was noted earlier for the two-stage
(or two-hit) model for lead. Figure 3 shows two ﬁndings
bearing on this question. First, that for many years after the
ﬁrst cases were documented, new cases continued to appear,
possibly because of the combination of aging and silent
damage. Second, in nonhuman primates exposed during
early development to lead [18] and methylmercury [19], a
long period elapsed before neurotoxic eﬀects made an overt
appearance.
The most serious gap is in our understanding of
methylmercury’s possible eﬀects on cognitive function dur-
ing aging lies in the domain of neuropsychological assess-
ment. Perhaps the absence of such data can be ascribed
to the most conspicuous signs of poisoning in adults;
that is, those listed in Table 3. They are so ﬂagrant that
more subtle outcomes, such as cognitive dysfunction, were8 International Journal of Alzheimer’s Disease
not pursued. No neuropsychologists were enlisted in the
numerous studies conducted by Japanese physicians and
scientists in the years following the onset of the poisoning.
Surveys of elderly Japanese in areas marked by elevated
exposures, as determined by biomarkers such as hair, or
less precisely, by geographic location, have tended to focus
on endpoints, such as paresthesias and ataxia, that are part
of a conventional neurological examination [41, 42]. In
two studies that evaluated subjective complaints, however,
“forgetfulness,” a cognitive term, emerged as a common
complaint [43, 44].
Once systematic neuropsychological assessments were
undertaken, however, they uncovered evidence of impair-
ment. Carta et al. [45] compared a group of 22 adult male
tuna ﬁsh eaters with 22 controls, both about 50 years of age,
on a neurobehavioral test battery. The tuna eaters exhibited
much higher levels of organic mercury in blood and hair.
Two cognitive tests diﬀerentiated the two groups statistically,
digit-symbol and color word reaction time, while overall
performance was inversely correlated with biomarker levels.
Chang et al. [46] took advantage of a Taiwanese pop-
ulation living in the vicinity of an abandoned chlor-alkali
factory; such factories typically use big tanks of elemental
mercury as an electrode. Fish in the area were heavily
contaminated because of previous mercury waste discharges
into the adjacent river where, as in most waterways,
microorganisms in bottom sediment convert the inorganic
mercury into the methyl species. Measures of total and
organic mercury in bloodindicated somewhat elevatedlevels
compared to US residents, but close to those of residents
of the Faroe Islands and the Republic of Seychelles, both
sites of large prospective studies of methylmercury eﬀects
on brain development [34, 35]. For the neurobehavioral
assessments, the authors relied upon the Cognitive Abilities
Screening Instrument (CASI) and the Mini-Mental State
Exam (MMSE). They then divided the population in two:
high blood and low blood methylmercury values. The two
groups achieved signiﬁcantly diﬀerent scores on the CASI
and MMSE, with the low ones superior. Although all the
subtests showed better scores by those with low values, three
subtests yielded signiﬁcant diﬀerences on their own: remote
memory, recent memory, and mental manipulation.
The published literature contains other studies pointing
in the same direction. For example, Yokoo et al. [47], study-
ing an Amazonian population, found correlations between
hair concentrations of methylmercury with performance
on several neuropsychological tests. It seems, then, even
with this small group of studies, that adult brains are not
as resistant to methylmercury neurotoxicity, compared to
developing brains, as had been believed. Chronic exposure,
combined with the diminished performance associated with
aging, may account for this unexpected sensitivity.
All three studies present the same conundrum. As with
all ﬁsh-consuming populations, unless they are followed
from conception onwards, it becomes virtually impossible
to diﬀerentiate the eﬀects of current exposure from those
occurring early in development.
The laboratory animal literature supports the view that
advanced age is a period during which the damage inﬂicted
by developmental or chronic exposure may ﬁrst emerge.
Spyker [36] showed a variety of adverse eﬀects such as
obesity, kyphosis, and impaired locomotion in old mice
exposed prenatally. Newland et al. [48, 49]f o u n dt h a t
that the adult consequences of developmental exposure
in rats can be reﬂected in how precisely subjects adjust
to new behavioral demands. In nonhuman primates, Rice
[19]a n dB u r b a c h e re ta l .[ 50] found enduring eﬀects
of developmental exposure on coordination and sensory
function in monkeys that appeared only many years after
cessation of dosing.
TheMinamataprogression, fromitsﬁrst focusonclinical
poisoning to determining who was actually a victim to the
more recent question of subtle neuropsychological eﬀects,
can be depicted by the pyramid in Figure 4, which actually
represents the kind of questions evoked by environmental
contaminants in general. It is often the case that only after
we see obvious signs of adverse eﬀects do we begin to probe
further and to search for the predecessors of such eﬀects.
5.Discussion
In 1956, in the midst of the continuing controversy over
the Minamata disaster, the Japanese government asked
Kumamoto University, located nearby, to undertake studies
of the outbreak. The researchers aﬃrmed the connection
between the outbreak of the disease and methylmercury
contamination resulting from waste discharges into Mina-
mata Bay by the Chisso chemical plant. The question of
compensation for victims then arose: who was injured and
what was the evidence? In 1973, the Research Committee
on Minamata Disease of Kumamoto University described
its dilemma in assigning compensation in these terms as
follows:
“...the problem about the relationship between
a small amount of methylmercury pollution for
a long period and its accumulation in the brain
still remains obscure...Subclinical Minamata
disease was sometimes revealed by detectable
symptoms during the aging process...The sub-
clinical Minamata disease...could be called a
delayed type of Minamata disease in aged peo-
ple.”
This statement highlights the issues posed in this paper.
Neurodegenerative disorders such as Alzheimer’s disease are
disorders of aging, and the primary risk factor, except for
the familial form, is age. To what extent their etiology and,
perhaps more narrowly, their rate of progression or latency
to clinical emergence is fostered by environmental contami-
nants is all but unknown at present. We can, however, note
howagingintersectswithneurotoxicantexposure[51].Many
manifestations of neurotoxicity, such as impaired sensory
acuity, mimic the natural course of aging. Some adverse
eﬀects may arise for the ﬁrst time in advanced age because it
is a period of declining compensatory margins. With aging,
for example, synaptic density decreases [52, 53]. Attrition of
nerve cells also occurs naturally as the brain ages but is alsoInternational Journal of Alzheimer’s Disease 9
accompanied by dendritic sprouting in those that remain.
Damage incurred earlier in life, as in mild polio infections
thatseemed tofade, may emerge latein life in theform ofthe
postpolio syndrome. Could parallel processes be induced by
neurotoxicants such as methylmercury?
(i) Early development,it now seems clear, is not the only
life stage during which the brain exhibits intensiﬁed
responsestotheadverseeﬀectsofchemicals.Vulnera-
bilitytotoxicprocessesrisesagainlateinlife;recovery
from damage is sluggish, and pharmacokinetic and
metabolic variables change with aging in ways that
recapitulate the imperfect defenses deployed by the
immature organism.
(ii) “Aging” is not a mechanistic explanation. Events
occurring during life must account for the changes.
Older brains are already high-maintenance proper-
ties, so that exposure to substances with neurotoxic
properties, such as certain metals, may accelerate the
process or exploit its dwindling capacities to resist
their eﬀects. From this vantage point, toxicants can
actinthreewaystodepressfunctionduringadvanced
age; they may interfere with brain development,
leavingalegacyofdiminished redundancynotappar-
ent until it is further compromised during aging;
they may hasten the progressive erosion of function
observed with certain abilities; they may exert greater
eﬀects in the aging brain because the aging nervous
system has already undergone a reduction in its
ability to withstand toxic challenges.
These arguments can be illustrated by Figures 5 and 6.
Figure5isbasedondatafromMcGeeretal.[31],whichtrace
the decline in substantia nigra cell number that occurs with
aging. Using the same rationale as that of Weiss and Simon
[39], it comparesthe McGeerdatawithtwo models ofrate of
decline.Oneshowsan additionalaccelerationof1%peryear,
the other one of 3% per year. At the 1% rate, remaining cell
numbershowsafall of40%ataboutage64while thebaseline
rate of decline would not reach that level until age 72.
Figure 6 converts these speculative projections into
their public health implications. It plots the age-indexed
prevalence of Parkinson’s disease for a baseline population
against one that has been advanced by 5 years and another
that has been advanced by 10 years. At age 65, the prevalence
comes to about 700/100,000 for the baseline population.
For the population advanced by 5 years, the ﬁgure becomes
about 1,200/100,000. This phenomenon is what happens
with disorders whose prevalence increases with age [54].
Figures 5 and 6 convey the core message of this paper.
It misleads us to conceive of environmental contaminants
such as metals as causes of neurodegenerative diseases such
as AD. To truly establish such a classiﬁcation requires data
from several biological levels ranging from epidemiology to
molecularmechanisms. With the three metals surveyedhere,
however, the available information is sturdy enough that we
can label them as potential contributors or risk factors for
the onset or progression of the disorder. Given the paucity
of information we now possess about the etiology of neu-
rodegenerative disorders, they warrant further investigation
about their inﬂuence on aging.
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